Controlled release pharmaceutical compositions for acid labile drugs

Details for Australian Patent Application No. 2006281414 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Onken, Jens; Sczesny, Frithjof; Shlieout, George; Koerner, Andreas; Koelln, Claus-Jurgen

Agent Watermark

Pub. Number AU-B-2006281414

PCT Pub. Number WO2007/020259

Priority 05107472.2 15.08.05 EP; 60/708,692 15.08.05 US

Filing date 15 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 1 September 2011

International Classifications

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/46 (2006.01) Medicinal preparations containing peptides

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/020259 Priority application(s): WO2007/020259

1 September 2011 Application Accepted

  Published as AU-B-2006281414

12 January 2012 Standard Patent Sealed

26 July 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee name from Solvay Pharmaceuticals GmbH to Abbott Products GmbH . Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281415-Pancreatin micropellet cores suitable for enteric coating

2006281407-Method and arrangement for liquefying a stream rich in hydrocarbons